Conagra Brands Boosts FY23 Adj. EPS Outlook - Update

By RTTNews Staff Writer   ✉   | Published:

While reporting financial results for the third quarter on Wednesday, branded food company Conagra Brands, Inc. (CAG) raised its adjusted earnings guidance for the full-year 2023, while trimming annual organic net sales growth outlook.

For fiscal 2023, the company now projects adjusted earnings in a range of $2.70 to $2.75 per share on organic net sales growth of 7 to 7.5 percent.

Previously, the company expected adjusted earnings in the range of $2.60 to $2.70 per share on organic net sales growth of 7 to 8 percent.

The Street is currently looking for earnings of $2.68 per share on a revenue growth of 7.2 percent to $12.36 billion for the year.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Volkswagen is recalling more than 143,000 Atlas sport utility vehicles or SUVs in the United States due to faulty airbags on the front passenger side. The German automaker warned against someone riding in that seat until the issue is corrected. Volkswagen Group of America, Inc.'s recall involves certain 2018-2021 Atlas and 2020 Atlas Cross Sport vehicles. Acuity Brands, Inc., an industrial technology company, announced Tuesday higher profit and net sales in its second quarter with growth in both business segments. Adjusted earnings topped market estimates, while top line missed view. Neil Ashe, Chairman, President and Chief Executive Officer of Acuity Brands, said, "We delivered solid performance again in the second quarter of 2023...." AMC Entertainment Holdings Inc. has reached a settlement in a shareholder lawsuit to proceed with converting its preferred stock into common shares. Following the settlement, which will provide investors additional shares as part of recapitalization, the movie theater chain's shares fell 22 percent in the extended trade on Monday, while its preferred shares grew 22 percent.